Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,944 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS.
Shefner JM, Andrews JA, Genge A, Jackson C, Lechtzin N, Miller TM, Cockroft BM, Meng L, Wei J, Wolff AA, Malik FI, Bodkin C, Brooks BR, Caress J, Dionne A, Fee D, Goutman SA, Goyal NA, Hardiman O, Hayat G, Heiman-Patterson T, Heitzman D, Henderson RD, Johnston W, Karam C, Kiernan MC, Kolb SJ, Korngut L, Ladha S, Matte G, Mora JS, Needham M, Oskarsson B, Pattee GL, Pioro EP, Pulley M, Quan D, Rezania K, Schellenberg KL, Schultz D, Shoesmith C, Simmons Z, Statland J, Sultan S, Swenson A, Berg LHVD, Vu T, Vucic S, Weiss M, Whyte-Rayson A, Wymer J, Zinman L, Rudnicki SA. Shefner JM, et al. Among authors: jackson c. Amyotroph Lateral Scler Frontotemporal Degener. 2021 May;22(3-4):287-299. doi: 10.1080/21678421.2020.1822410. Epub 2020 Sep 24. Amyotroph Lateral Scler Frontotemporal Degener. 2021. PMID: 32969758 Free PMC article. Clinical Trial.
ALSUntangled update 4: investigating the XCell-Center.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2010 May 3;11(3):337-8. doi: 10.3109/17482961003755005. Amyotroph Lateral Scler. 2010. PMID: 20443222 No abstract available.
ALSUntangled No. 6: Investigating Marty Murray's method.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2010 Oct;11(5):494-6. doi: 10.3109/17482968.2010.511129. Amyotroph Lateral Scler. 2010. PMID: 20839919 No abstract available.
ALSUntangled No. 8: Low dose naltrexone for ALS.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2011 Jan;12(1):76-8. doi: 10.3109/17482968.2010.544386. Epub 2010 Dec 21. Amyotroph Lateral Scler. 2011. PMID: 21174518 No abstract available.
The ALS Nutrition/NIPPV Study: design, feasibility, and initial results.
Kasarskis EJ, Mendiondo MS, Wells S, Malguizo MS, Thompson M, Healey M, Kryscio RJ; ALS Nutrition/NIPPV Study Group. Kasarskis EJ, et al. Amyotroph Lateral Scler. 2011 Jan;12(1):17-25. doi: 10.3109/17482968.2010.515225. Amyotroph Lateral Scler. 2011. PMID: 21271789 Clinical Trial.
ALSUntangled No. 10: Luteolin and Lutimax.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2011 May;12(3):235-7. doi: 10.3109/17482968.2011.578872. Amyotroph Lateral Scler. 2011. PMID: 21545238 No abstract available.
ALSUntangled No. 11: Nu Tech Mediworld.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2011 Jul;12(4):309-11. doi: 10.3109/17482968.2011.589205. Amyotroph Lateral Scler. 2011. PMID: 21702736 No abstract available.
4,944 results